These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25671486)

  • 21. Palliative treatment of malignant ascites #177.
    LeBlanc K; Arnold RM
    J Palliat Med; 2010 Aug; 13(8):1028-9. PubMed ID: 20712467
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical signs for the general dental practitioner. Case 107. Chronic liver disease.
    Bain SC; Baker K
    Dent Update; 2013 Dec; 40(10):857. PubMed ID: 24597038
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of chronic ascites due to right-sided heart failure by transjugular intrahepatic portosystemic shunt stent-implantation after orthotopic heart transplant.
    Dakkak AR; Welp H; Schmidt H; Koehler M; Scheld HH; Sindermann JR
    Exp Clin Transplant; 2011 Apr; 9(2):156-8. PubMed ID: 21453237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and therapy of ascites in liver cirrhosis].
    Gülberg V; Gerbes AL
    Internist (Berl); 1998 Mar; 39(3):254-62. PubMed ID: 9561446
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of ascites complicated with liver cirrhosis].
    Sato S; Suzuki K
    Nihon Naika Gakkai Zasshi; 1991 Oct; 80(10):1631-6. PubMed ID: 1774530
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of patients with cirrhosis and ascites.
    Runyon BA
    Semin Liver Dis; 1997; 17(3):249-60. PubMed ID: 9308129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
    Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
    Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of ascites in cirrhotic patients].
    Kurosaki M; Nakanishi H; Izumi N
    Nihon Shokakibyo Gakkai Zasshi; 2017; 114(1):27-34. PubMed ID: 28070092
    [No Abstract]   [Full Text] [Related]  

  • 30. Cirrhotic ascites: pathogenesis and management.
    Garcia-Tsao G
    Gastroenterologist; 1995 Mar; 3(1):41-54. PubMed ID: 7743121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefit of TIPS for patients with refractory or recidivant ascites: serum bilirubin may make the difference.
    Gerbes AL; Gülberg V
    Hepatology; 2005 Jan; 41(1):217. PubMed ID: 15619245
    [No Abstract]   [Full Text] [Related]  

  • 32. [TIPS: value in the treatment of therapy refractory ascites].
    Staritz M; Jaeger O; Matschke H; Riesterer H; Sauer B
    Z Gastroenterol; 2000 Aug; 38(8):655-6. PubMed ID: 11031792
    [No Abstract]   [Full Text] [Related]  

  • 33. [Dysfunction of a TIPS (transjugular intrahepatic porto-systemic shunt) and chylous ascites].
    Rovira E; Molés JR; Hinojosa J; Primo J; Gonzalvo F; Albert A
    Rev Esp Enferm Dig; 1997 Jun; 89(6):475-7. PubMed ID: 9303612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of ascites in patients with chronic liver disease.
    Aiza I; Perez GO; Schiff ER
    Am J Gastroenterol; 1994 Nov; 89(11):1949-56. PubMed ID: 7942716
    [No Abstract]   [Full Text] [Related]  

  • 35. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic hydrothorax.
    Strauss RM; Boyer TD
    Semin Liver Dis; 1997; 17(3):227-32. PubMed ID: 9308127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
    Albillos A; Bañares R; González M; Catalina MV; Molinero LM
    J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of ascites in liver cirrhosis].
    Gramkow M; Christensen E
    Ugeskr Laeger; 1994 Sep; 156(37):5256-65. PubMed ID: 7941060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of surgery in the treatment of refractory ascites in cirrhotic patients].
    Borie DC; Vaillant JC; Breton S; Hannoun L
    Ann Chir; 1999; 53(10):966-72. PubMed ID: 10670142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of ascitis in patients with cirrhosis].
    Arfaoui D; Ajmi S
    Tunis Med; 2007 Feb; 85(2):91-5. PubMed ID: 17665651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.